Skip to content
Making Molecular Diagnostics More Accessible

Seegene USA is a leading developer of multiplex molecular assays and automated solutions for US labs. Seegene aims to support a healthy life for everyone by creating a new diagnostic paradigm.

Making Molecular Diagnostics More Accessible

Seegene USA is a leading developer of multiplex molecular assays and automated solutions for US labs. Seegene aims to support a healthy life for everyone by creating a new diagnostic paradigm.

One Sample,
Many Answers

Seegene’s solutions offer user friendly workflows for the laboratories and comprehensive molecular PCR results that enable fact-based research. Our technology makes it possible to detect hundreds of targets on a single platform.

Infectious Diseases
Infectious Diseases
High Multiplex PCR Products

Seegene provides molecular PCR products capable of detecting multiple targets simultaneously. Our high multiplex assays deliver comprehensive information using our proprietary technology that produces high multiplex results from a single channel in a PCR reaction.

Detect CT, NG, TV, MG, and more STIs with confidence

Cover all your lab’s respiratory needs

Detection and identification of 18 targets

Molecular solutions for GI bacteria, viruses, and parasites

Learn more about Seegene’s high multiplex real-time PCR technologies
Benefits of
Seegene’s Solution
For Technicians / Labs
  • Simultaneous detection of multiple pathogens in a single test
  • Affordable detection and identification which minimizes labor and cost
  • Provide comprehensive tests on one platform
  • Fast turnaround time of under 4 hours (includes extraction and PCR time)
  • Fewer runs for detecting pathogens of interest
Benefits of
Seegene’s Solution
For Technicians / Labs
  • Simultaneous detection of multiple pathogens in a single test
  • Affordable detection and identification which minimizes labor and cost
  • Provide comprehensive tests on one platform
  • Fast turnaround time of under 4 hours (includes extraction and PCR time)
  • Fewer runs for detecting pathogens of interest
News & Events

Seegene Announces Collaboration with Microsoft to Realize ‘a World Free from All Diseases’

Press Release For immediate release Seegene Announces Collaboration with Microsoft to Realize ‘a World Free from All Diseases’ Strategic collaboration…

Read More
Stay up to date on our latest news and events
Upcoming Events

SCACM

APHL

Blog
Doctor Takes A Multiplex PCR Test Sample From A Young Girl

A New Normal: Surveillance and Epidemiology of Severe Acute Respiratory Pathogens Using Multiplex PCR

Long before SARS-CoV-2 turned the world upside down, severe acute respiratory disease was already a major cause of morbidity and mortality for adults and children all over the world. As…

Read More
SGHQ Open Innovation Program

Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature

Together, we can create a disease-free future Register for the webcast - A replay will be available for those who register! Click ▶ Nature Research (workcast.com) Date: Thursday, September 21,…

Read More

Laboratory-Developed Tests: A Best Practices Primer

Laboratory-developed tests (LDTs) played a critical role during the COVID-19 pandemic. In fact, many current molecular tests were developed as laboratory-developed tests, outside the strict regulatory framework of the U.S.…

Read More
Back To Top
Search